Global Immunohematology Market by Product (Analyzers & Systems, Reagents), Application (Blood Transfusion, Laboratory Resolution of Percentage Problems, Organ Transplantation), End User - Forecast 2024-2030- Product Image

Sale

Global Immunohematology Market by Product (Analyzers & Systems, Reagents), Application (Blood Transfusion, Laboratory Resolution of Percentage Problems, Organ Transplantation), End User - Forecast 2024-2030

Report
183 Pages
March 2024
Region: Global
360iResearch™
ID: 5454916

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Immunohematology Market size was estimated at USD 2.28 billion in 2023, USD 2.46 billion in 2024, and is expected to grow at a CAGR of 7.68% to reach USD 3.84 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunohematology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunohematology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunohematology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomed Global, Cardinal Health, Inc., CSL Limited, Grifols, S.A., Immucor, Inc., Merck KGaA, Ortho-Clinical Diagnostics, Inc., Quotient Suisse S.A., Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Immunohematology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Analyzers & Systems
- Reagents
Application
- Blood Transfusion
- Laboratory Resolution of Percentage Problems
- Organ Transplantation
- Pregnancy
End User
- Blood Banks
- Diagnostic Laboratories
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Immunohematology Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunohematology Market?
What are the technology trends and regulatory frameworks in the Immunohematology Market?
What is the market share of the leading vendors in the Immunohematology Market?
Which modes and strategic moves are suitable for entering the Immunohematology Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immunohematology Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of leukemia and other hematological disorder
5.1.1.2. Improvements in the healthcare infrastructure and the development of blood banks and trauma centers
5.1.1.3. Ongoing government initiatives to increase awareness of blood donations
5.1.2. Restraints
5.1.2.1. High cost of maintenance and limited awareness
5.1.3. Opportunities
5.1.3.1. Availability of innovative transfusion systems and next-generation immunohematology devices
5.1.3.2. Ongoing research and development programs for the advancement of new products in immunohematology
5.1.4. Challenges
5.1.4.1. Dearth of skilled professionals and stringent regulatory policies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immunohematology Market, by Product

6.1. Introduction
6.2. Analyzers & Systems
6.3. Reagents

7. Immunohematology Market, by Application

7.1. Introduction
7.2. Blood Transfusion
7.3. Laboratory Resolution of Percentage Problems
7.4. Organ Transplantation
7.5. Pregnancy

8. Immunohematology Market, by End User

8.1. Introduction
8.2. Blood Banks
8.3. Diagnostic Laboratories
8.4. Hospitals

9. Americas Immunohematology Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Immunohematology Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Immunohematology Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Beckman Coulter, Inc.
13.1.3. Becton Dickinson and Company
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. Biomed Global
13.1.6. Cardinal Health, Inc.
13.1.7. CSL Limited
13.1.8. Grifols, S.A.
13.1.9. Immucor, Inc.
13.1.10. Merck KGaA
13.1.11. Ortho-Clinical Diagnostics, Inc.
13.1.12. Quotient Suisse S.A.
13.1.13. Siemens Healthineers AG
13.1.14. Sysmex Corporation
13.1.15. Thermo Fisher Scientific, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. IMMUNOHEMATOLOGY MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOHEMATOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOHEMATOLOGY MARKET DYNAMICS
FIGURE 7. IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IMMUNOHEMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOHEMATOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOHEMATOLOGY MARKET SIZE, BY LABORATORY RESOLUTION OF PERCENTAGE PROBLEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOHEMATOLOGY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOHEMATOLOGY MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOHEMATOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOHEMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. IMMUNOHEMATOLOGY MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Beckman Coulter, Inc.
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Biomed Global
Cardinal Health, Inc.
CSL Limited
Grifols, S.A.
Immucor, Inc.
Merck KGaA
Ortho-Clinical Diagnostics, Inc.
Quotient Suisse S.A.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	183
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.46 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.84 Billion
Compound Annual Growth Rate	7.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Immunohematology Global Market Report 2024

Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Immunohematology Analyzers and Reagents - Global Strategic Business Report

Immunohematology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Global Immunohematology Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

About the Immunohematology Market